Leigh R. Hochberg, MD, PhD is a neurointensivist and vascular neurologist at Massachusetts General Hospital and Senior Lecturer on Neurology at Harvard Medical School; the L. Herbert Ballou University Professor of Engineering and Professor of Brain Science at Brown University; and Associate Director, VA Center for Neurorestoration and Neurotechnology in Providence. He also directs the MGH Center for Neurotechnology and Neurorecovery, co-founded the Implantable BCI Collaborative Community, and is the IDE Sponsor-Investigator and PI of the BrainGate clinical trials, conducted by a consortium of scientists and clinicians at Brown, Emory, Mass General, VA Providence Healthcare, Stanford, and UC-Davis. Dr. Hochberg’s research focuses on the development and testing of novel neurotechnologies to help people with paralysis and other neurologic disorders.

Dr. Hochberg and his research with the BrainGate team have been honored with the Joseph Martin Prize in Basic Research, the Herbert Pardes Prize for Excellence in Clinical Research, the first Israel Brain Technologies international B.R.A.I.N. Prize, presented by President Shimon Peres, the Derek Denny-Brown Young Neurological Scholar Award, the CERF Prize in Medical Engineering, the Paul B. Magnuson Award from the US Department of Veterans Affairs, and the Sean M. Healey International Prize for Innovation in ALS. Dr. Hochberg’s BrainGate research, which has been published Nature, the New England Journal of Medicine, Lancet, Science Translational Medicine, eLife, the Journal of Neuroscience, the Journal of Neural Engineering, and others, is supported by the VA Rehabilitation R&D Service, the National Institutes of Health including the BRAIN Initiative/NINDS and NIDCD, and philanthropies including the ALS Association and the American Heart Association.